Antifolate activity of isoaminopterin in HeLa cells.

Antimicrobial Agents and Chemotherapy
H Rosemond-Hornbeak, M Gopal Nair

Abstract

The antifolate activity and the transport characteristics of isoaminopterin (IA) in HeLa cells were studied and compared with those of methotrexate (MTX). Both IA and MTX inhibited the incorporation of [2-(14)C]deoxyuridine into HeLa cell DNA by 50% at a concentration of 0.09 muM by 8 h postaddition of the compounds. Unlike MTX, the inhibition of DNA synthesis by IA was time dependent and reached a maximum at 24 h. IA-induced inhibition was due to interference with folate metabolism, since it could be completely reversed with N(5)-formyl-tetrahydrofolate. Competitive transport experiments between IA and either radiolabeled MTX or radiolabeled folate showed that IA preferentially uses the reduced folate/MTX transport system. IA inhibited MTX uptake by 50% at a concentration of 6.8 muM but had a negligible effect on folate transport.

References

Jun 1, 1976·Journal of Medicinal Chemistry·M G Nair, P T Campbell
Jan 12, 1976·Biochemical and Biophysical Research Communications·D W HorneC Wagner
Jun 13, 1975·The Journal of Organic Chemistry·M G NairC M Baugh
Feb 1, 1974·Journal of Medicinal Chemistry·M G Nair, C M Baugh
Dec 1, 1974·Journal of Medicinal Chemistry·M G NairC M Baugh
Nov 30, 1971·Annals of the New York Academy of Sciences·D J Hutchison
Nov 30, 1971·Annals of the New York Academy of Sciences·E D Thomas, R Storb
Nov 30, 1971·Annals of the New York Academy of Sciences·G D Weinstein
Jan 1, 1967·Annual Review of Medicine·J R Bertino, D G Johns

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.